Advances in the Role of SIRT3 in Vascular Remodeling in Hypertension
Biomolecules · 16.07.2026 · 16 (7) · 1037
DOI: 10.3390/biom16071037 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 16.07.2026. Verfasst von Abdul Wahid und 5 weiteren Autor:innen. Beteiligte Einrichtung: International School of Medicine, Changsha Medical University, 1501 Leifeng Road, Changsha 410219, China. Hauptthemen laut MEDLINE: Sirtuin 3, Hypertension, Vascular Remodeling. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Provincial Natural Science Foundation of Hunan Province.
Abstract (Originalsprache)
Hypertension-induced vascular remodeling is a major contributor to cardiovascular morbidity and is characterized by endothelial dysfunction, vascular smooth muscle cell phenotypic switching, fibrosis, and inflammation. Sirtuin 3 (SIRT3), a mitochondrial nicotinamide adenine dinucleotide-dependent deacetylase, plays an important role in maintaining mitochondrial homeostasis, regulating redox balance, and modulating cellular energy metabolism. Emerging evidence suggests that SIRT3 deficiency accelerates hypertensive vascular remodeling through multiple mechanisms. In vascular smooth muscle cells (VSMCs), reduced SIRT3 activity enhances mitochondrial reactive oxygen species generation, promotes glycolytic reprogramming, and contributes to phenotypic switching and proliferation. In endothelial cells, SIRT3 mitigates oxidative stress (OS) by regulating the activity of superoxide dismutase 2, thereby preserving nitric oxide (NO) bioavailability and improving vascular function. SIRT3 also suppresses fibroblast-to-myofibroblast transformation by inhibiting the transforming growth factor-β/Smad3 pathway, thereby reducing vascular fibrosis. Furthermore, SIRT3 regulates macrophage metabolic reprogramming and autophagy, inhibits NLRP3 (NOD-, LRR- and pyrin domain-containing protein 3) inflammasome activation, and attenuates vascular inflammation. In perivascular adipose tissue, SIRT3 deficiency exacerbates angiotensin II-induced fibrosis and cytokine secretion, thereby aggravating vascular dysfunction. Collectively, SIRT3 acts as a mitochondrial regulator against hypertension-induced oxidative and inflammatory injury. Targeting SIRT3-dependent pathways may represent a promising therapeutic approach to restore vascular homeostasis and prevent hypertensive vascular remodeling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- International School of Medicine, Changsha Medical University, 1501 Leifeng Road, Changsha 410219, China.
- Department of Cardiology of the Third Xiang-Ya Hospital, Central South University, 138 Tongzipo Road, Changsha 410013, China.
- Department of Biochemistry and Biotechnology, School of Biomedical Sciences, Khwaja Yunus Ali University, Sirajganj 6751, Bangladesh.
ORCID-Profile: Md Tariqul Islam
Förderung
- Provincial Natural Science Foundation of Hunan Province
Zitieren
APA
Wahid, A., Islam, M. T., Rana, M. S., Parvin, M. M., Weng, C., & Tang, X. (2026). Advances in the Role of SIRT3 in Vascular Remodeling in Hypertension. Biomolecules, 16(7), 1037. https://doi.org/10.3390/biom16071037
Vancouver
Wahid A, Islam MT, Rana MS, Parvin MM, Weng C, Tang X. Advances in the Role of SIRT3 in Vascular Remodeling in Hypertension. Biomolecules. 2026;16(7):1037. doi:10.3390/biom16071037
BibTeX
@article{Wahid2026,
author = {Wahid, Abdul and Islam, Md Tariqul and Rana, Md Sohel and Parvin, Mst Morium and Weng, Chunyan and Tang, Xiaohong},
title = {Advances in the Role of SIRT3 in Vascular Remodeling in Hypertension},
journal = {Biomolecules},
year = {2026},
volume = {16},
number = {7},
pages = {1037},
doi = {10.3390/biom16071037}
}
EUVIMED